Mdxhealth received a non-compliance notice from Nasdaq on July 2 after failing to maintain the exchange's minimum bid price requirement [1].
This notice places the company at risk of delisting if it cannot rectify the pricing deficiency. Maintaining listing status is critical for public companies to ensure liquidity and investor access to their shares.
The breach involves Nasdaq Listing Rule 5550 (a) (2), which requires listed securities to maintain a minimum bid price of $1.00 [1], [2] per share. According to the notice, the company fell below this threshold, triggering the regulatory action.
Specific guidelines regarding this breach are outlined in Nasdaq Listing Rule 5810 (c) (3) (A). This rule states that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 [2] consecutive business days.
"Nasdaq Listing Rule 5550 (a) (2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810 (c) (3) (A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days," TMCnet said [2].
Companies facing this type of notice typically have a set window to regain compliance. Common strategies to address a bid price deficiency include executing a reverse stock split, or implementing other corporate actions to increase the share price above the required level.
“Mdxhealth received a non-compliance notice from Nasdaq on July 2”
A non-compliance notice is a formal warning that a company's stock no longer meets the minimum standards for trading on a major exchange. If Mdxhealth cannot raise its bid price back to $1.00 within the allotted timeframe, it faces potential delisting, which often leads to the stock being moved to the over-the-counter (OTC) markets where trading volume and institutional interest are typically much lower.
